Literature DB >> 10709111

Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues.

V Wautot1, S Khodaei, L Frappart, N Buisson, E Baro, G M Lenoir, A Calender, C X Zhang, G Weber.   

Abstract

We have investigated the endogenous expression of menin, a protein encoded by the gene mutated in multiple endocrine neoplasia type 1 (MEN1). Western blot analysis showed strong expression of menin as a 68 kDa protein in all of 7 human and primate cell lines tested. In a panel of 12 fetal human tissue extracts, 68 kDa menin was readily detected in brain cortex, kidney, pituitary, testis and thymus and weakly detected in thyroid. Reproducible bands other than 68 kDa were observed in adrenal and heart, whereas menin was undetectable in liver, lung, pancreas and skin. Analysis of synchronized HeLa cells revealed no variation in the amount or size of menin throughout the cell cycle. Protein expression was compared between lymphoblastoid cell lines from healthy controls and MEN1 patients carrying nonsense mutations on 1 allele. No truncated protein was detected in either cytoplasmic or nuclear fractions in mutation-carrying cells. The expression level and cellular location of full-length menin did not differ between cell lines derived from MEN1 patients and healthy donors. This suggests that the wild-type allele has been up-regulated in mutation-carrying cells to compensate for the loss of 1 functional allele. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10709111     DOI: 10.1002/(sici)1097-0215(20000315)85:6<877::aid-ijc23>3.0.co;2-f

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Menin induces endodermal differentiation in aggregated P19 stem cells by modulating the retinoic acid receptors.

Authors:  Jyotshnabala Kanungo; Settara C Chandrasekharappa
Journal:  Mol Cell Biochem       Date:  2011-08-11       Impact factor: 3.396

2.  A novel one-step purification of mouse factor IX.

Authors:  Vijaya S Pilli; William E Plautz; Dougald M Monroe; Rinku Majumder
Journal:  Thromb Res       Date:  2016-01-26       Impact factor: 3.944

3.  Menin represses tumorigenesis via repressing cell proliferation.

Authors:  Ting Wu; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-05-16       Impact factor: 6.166

4.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization.

Authors:  Yan Wang; Atsushi Ozawa; Shadia Zaman; Nijaguna B Prasad; Settara C Chandrasekharappa; Sunita K Agarwal; Stephen J Marx
Journal:  Cancer Res       Date:  2010-12-02       Impact factor: 12.701

Review 6.  The MEN1 gene and associated diseases: an update.

Authors:  T Tsukada; K Yamaguchi; T Kameya
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

7.  Menin induces apoptosis in murine embryonic fibroblasts.

Authors:  Robert W Schnepp; Hua Mao; Stephen M Sykes; Wei-Xing Zong; Albert Silva; Ping La; Xianxin Hua
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

8.  Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).

Authors:  Pierre Goudet; Arnaud Murat; Catherine Cardot-Bauters; Philippe Emy; Eric Baudin; Hélène du Boullay Choplin; Yves Chapuis; Jean-Louis Kraimps; Jean-Louis Sadoul; Antoine Tabarin; Bruno Vergès; Bruno Carnaille; Patricia Niccoli-Sire; Annie Costa; Alain Calender
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

9.  Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues.

Authors:  Christine A Biondi; Michael G Gartside; Paul Waring; Kelly A Loffler; Mitchell S Stark; Mark A Magnuson; Graham F Kay; Nicholas K Hayward
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.

Authors:  Sandra Fontanière; Huguette Casse; Philippe Bertolino; Chang Xian Zhang
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.